Under construction – not a live service
Sign in
Not yet taking people in UgandaNo phase

KeySuite Device Tested for Abdominal Tumor Biopsies in Uganda

Tests the KeySuite surgical devices in Ugandan patients with abdominal tumors during biopsy surgery.

Plain-language title generated from the registry record
Registry title: KeyScope Study in Uganda

Key facts

Where
Kampala, UgandaSee the site

Where in Uganda

  • Uganda Cancer InstituteKampala, UgandaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Duke University
Trial code
NCT06212570
Record updated
10 November 2026
Original description
KeyScope and KeyLoop (collectively called KeySuite) are laparoscopic prototypes that the investigators have designed for the resources, needs and challenges of low- and middle- income countries (LMICs). KeyScope is a laparoscope that plugs into a laptop computer to display images during surgery. It links to a telementoring application so that experienced surgeons can mentor surgeons in capacity-building partnerships. KeyLoop is a laparoscopic retractor that lifts the abdominal wall during surgery, obviating the need for a constant power supply and medical-grade carbon dioxide.Read full original descriptionShow less

KeyScope: First-In-Human Clinical Study for Cancer Diagnosis in Uganda

KeyScope and KeyLoop (collectively called KeySuite) are laparoscopic prototypes that the investigators have designed for the resources, needs and challenges of low- and middle- income countries (LMICs). KeyScope is a laparoscope that plugs into a laptop computer to display images during surgery. It links to a telementoring application so that experienced surgeons can mentor surgeons in capacity-building partnerships. KeyLoop is a laparoscopic retractor that lifts the abdominal wall during surgery, obviating the need for a constant power supply and medical-grade carbon dioxide.

The investigators will perform a clinical First-in-Human study at the Uganda Cancer Institute. Ugandan surgeons will use the KeySuite devices to perform biopsies of intra-abdominal tumors.

Inclusion: diagnosis of intra-abdominal mass suspicious for cancer; body mass index (BMI) of 18-30; weight 20-100kg; biopsy necessary to determine cancer diagnosis and classify pathology; surgeon determine that laproscopic biopsy it technically appropriate.

Exclusion: previous major abdominal surgery; significant comorbidities; current pregnancy.

ClinicalTrials.gov NCT06212570